FARO ECONÓMICOSTOCK ANALYSIS

ODTX — analysis and forecast

$19.53-0.1% todayOdyssey Therapeutics, Inc.
Verdict
Neutral
RSI (14)
71
MACD
▲ rising
Trend
Downtrend
Volatility
77%
52w range
30%

🧬 Faro multibagger DNA

Does it look today like the big multibaggers (×10, ×100) did when they started? 7 traits measured with public data.

48/ 100
Mixed

Strongest: Room to grow and Balance sheet. Most lacking: Business quality and Price vs. growth.

Room to grow100

Worth $939 M. To grow ×10 it would have to reach $9.4 B.

Sales engine35

Not enough sales data.

Business quality0

Gross margin 0%, operating margin -156393%, return on equity —.

Cash it generates40

No free cash flow data.

Price vs. growth12

Trades at 9480.6× sales with no growth to back it.

Balance sheet100

Net cash equal to 30% of its value.

Faro seal57

No recent federal contracts on the radar · inside a Faro megatrend · insiders own 6.2%.

⏱️ Timing (not scored): mid-range over 12 months (32%) · below its 200-day average · beating the S&P 500 by 8 points over 12 months.

Built on the traits of 365 stocks that went ×100 (Mayer, 1962–2014) and 464 that went ×10 (Yartseva, 2009–2024), plus the Faro thesis. It does not predict the price and is not a recommendation. How it works and the ranking →

🔢 What the numbers say

The last 12 months, in plain words

🗓️ Forecast by horizon

Directional bias · probability of rising · expected price and likely range (68%)

HorizonBiasProb. upExpected price68% range
1 dayNeutral52%$19.56 +0.1%$18.64 – $20.52
3 daysNeutral52%$19.61 +0.4%$18.04 – $21.32
1 weekNeutral53%$19.67 +0.7%$17.66 – $21.91
15 daysNeutral53%$19.81 +1.4%$17.01 – $23.08
1 monthBullish54%$20.12 +3.0%$16.13 – $25.10
3 monthsBullish57%$21.36 +9.4%$14.56 – $31.33

Recent momentum: -6.3% over 20 days · -7.7% over 60 days. The further out the horizon, the wider and more uncertain the forecast.

📈 Probability cone

📜 Government contracts

We have no notable federal contract on file for ODTX. You can look it up yourself at USASpending.gov or in the Government Sources hub.

📚 Go deeper: Faro Library reports

PDF reports built from official filings. Your first one is free, no email; then $1.99 each or all 33 for $25 — included in Navigator and Admiral.

See all 33 reports →

❓ Frequently asked questions about ODTX

Could ODTX be the next NVIDIA?

Its Faro multibagger DNA is 48/100 (mixed): it measures how much it looks today like the big multibaggers did when they started (size, sales growth, quality, cash, price versus growth, balance sheet and public contracts). To grow ×10 it would need to be worth about 10 times today's value. Not a prediction or a recommendation.

How much has ODTX gone up in the last year?

Odyssey Therapeutics (ODTX) is up 18.9% over the period with data and trades at $19.53, 32.1% below its 52-week high ($28.76). 52-week range: $15.56 – $28.76.

How volatile is ODTX stock?

Its annualized volatility is around 77% and its worst drop from a peak over the last year was 42.3%. For reference, the S&P 500 usually moves 15–20% a year.

Does ODTX have U.S. government contracts?

There is no notable federal contract in Faro's register. You can search USASpending.gov.

Is now a good time to buy ODTX?

Nobody can know that for sure and this page is not a buy recommendation. What the data shows today: neutral technical bias, RSI 71 (overbought zone), price below its 50-day average and an estimated 54% probability of being higher in 1 month. Use it as a starting point for research, not as a signal.

🧠 How it is calculated

The verdict combines trend (20/50/200 moving averages), momentum (RSI, MACD), mean reversion (Bollinger Bands), conviction (volume) and historical drift, weighted differently for each horizon. Uncertainty is modeled with a lognormal probability cone (geometric Brownian motion). This is statistical analysis, not a crystal ball.

🔦 Keep analyzing

Other stocks Faro watches

🔮 Oracle Pro 📈 Trading Room 📅 Calendar

⚠️ Educational tool. Not financial advice. Forecasts are statistical estimates based on historical volatility; the market can do the opposite. Data via Yahoo Finance. Always verify before trading. The decisions are yours.